Structures published

Total: 20

N,N'-(Ethane-1,2-diyl)bis(2-chlorobenzamide)

C₁₆H₁₄Cl₂N₂O₂

Mohamooda Sumaya, U.Reuben Jonathan, D.Dravida Thendral, E. R. A.Revathi, B. K.Usha, G.

IUCrData (2016) 1, 7 x161190

a=4.9667(6)Å b=23.701(3)Å c=7.1113(8)Å

α=90° β=104.189(4)° γ=90°

(E)-1-(4-Aminophenyl)-3-[4-(benzyloxy)phenyl]prop-2-en-1-one

C₂₂H₁₉NO₂

Hannah Clara, T.Prasana, Johanan Christian Reuben Jonathan, D.Revathi, B. K.Usha, G.

IUCrData (2016) 1, 9 x161371

a=21.3428(8)Å b=5.7635(2)Å c=28.2870(11)Å

α=90° β=91.6340(10)° γ=90°

(E)-4-(4-Ethoxyphenyl)but-3-en-2-one

C₁₂H₁₄O₂

Kamalini, G. Joseline Sheeba Sugaraj, Samuel R.Reuben Jonathan, D.Revathi, B. K.Usha, G.

IUCrData (2016) 1, 4 x160610

a=5.7634(2)Å b=8.2218(2)Å c=12.0915(3)Å

α=105.5413(14)° β=102.5395(16)° γ=97.4291(14)°

2,4-Dichloro-N-{[1-(2,4-dichlorobenzoyl)piperidin-4-yl]methyl}benzamide

C₂₀H₁₈Cl₄N₂O₂

Gomathi, S.Reuben Jonathan, D.Dravida Thendral, E. R. A.Revathi, B. K.Usha, G.

IUCrData (2016) 1, 6 x160919

a=8.2338(2)Å b=10.9617(2)Å c=12.2646(3)Å

α=76.2390(10)° β=83.5710(10)° γ=80.4070(10)°

(4-Chlorophenyl)(4-methylpiperidin-1-yl)methanone

C₁₃H₁₆ClNO

Srividya, J.Reuben Jonathan, D.Revathi, B. K.Divya Bharathi, M.Anbalagan, G.

Acta Crystallographica Section E (2020) 76, 4 534-538

a=6.6286(4)Å b=8.1569(5)Å c=12.0061(8)Å

α=96.803(3)° β=101.506(3)° γ=98.511(3)°

4-Chloro-N-[2-(piperidin-1-yl)ethyl]benzamide monohydrate

C₁₄H₁₉ClN₂O_,H₂O

Prathebha, K.Reuben Jonathan, D.Revathi, B. K Sathya, S.Usha, G.

Acta Crystallographica Section E (2015) 71, 1 o39-o40

a=14.9115(6)Å b=6.6899(3)Å c=15.6215(7)Å

α=90.00° β=102.956(2)° γ=90.00°

2-Chloro-1-(3-ethyl-2,6-diphenylpiperidin-1-yl)ethanone

C₂₁H₂₄ClNO

Shreevidhyaa Suressh, V.Revathi, B. K.Abdul Basheer, S.Ponnuswamy, S.Usha, G.

Acta Crystallographica Section E (2015) 71, 2 o122

a=8.5971(9)Å b=12.9080(13)Å c=17.1114(16)Å

α=90.00° β=100.501(5)° γ=90.00°

3-(4-Methoxyphenyl)-2,3-dihydro-1H-naphtho[2,1-b]pyran-1-one

C₂₀H₁₆O₃

Vasanthi, R.Reuben Jonathan, D.Elizhlarasi, K. S.Revathi, B. K.Usha, G.

Acta Crystallographica Section E (2015) 71, 5 o332

a=7.3612(3)Å b=17.8540(9)Å c=11.9465(6)Å

α=90.00° β=105.697(2)° γ=90.00°

4-Methyl-N-[2-(piperidin-1-yl)ethyl]benzamide monohydrate

C₁₅H₂₂N₂O_,H₂O

Revathi, B. K.Reuben Jonathan, D.Sathya, S.Prathebha, K.Usha, G.

Acta Crystallographica Section E (2015) 71, 5 o359-o360

a=14.8504(17)Å b=6.8243(6)Å c=15.0070(18)Å

α=90.00° β=98.653(4)° γ=90.00°

(E)-3-(3,4-Dimethoxyphenyl)-1-(1-hydroxynaphthalen-2-yl)prop-2-en-1-one

C₂₁H₁₈O₄

Ezhilarasi, K. S.Reuben Jonathan, D.Vasanthi, R.Revathi, B. K.Usha, G.

Acta Crystallographica Section E (2015) 71, 5 o371-o372

a=9.8784(10)Å b=15.4108(15)Å c=11.2288(11)Å

α=90° β=92.674(2)° γ=90°

(4-Hydroxypiperidin-1-yl)(4-methylphenyl)methanone

C₁₃H₁₇NO₂

Revathi, B. K.Reuben Jonathan, D.Kalai Sevi, K.Dhanalakshmi, K.Usha, G.

Acta Crystallographica Section E (2015) 71, 11 o817-o818

a=23.933(5)Å b=6.3317(12)Å c=8.0269(14)Å

α=90.00° β=90.00° γ=90.00°

[4-(Chloromethyl)phenyl](4-hydroxypiperidin-1-yl)methanone

C₁₃H₁₆ClNO₂

Revathi, B. K.Reuben Jonathan, D.Kalai Sevi, K.Dhanalakshmi, K.Usha, G.

Acta Crystallographica Section E (2015) 71, 10 o703-o704

a=8.4131(3)Å b=9.6211(4)Å c=15.6780(6)Å

α=80.917(3)° β=89.240(2)° γ=88.395(2)°

(4-Hydroxypiperidin-1-yl)[4-(trifluoromethyl)phenyl]methanone

C₁₃H₁₄F₃NO₂

Revathi, B. K.Reuben Jonathan, D.Kalai Sevi, K.Dhanalakshmi, K.Usha, G.

Acta Crystallographica Section E (2015) 71, 10 o790-o791

a=16.1328(14)Å b=6.8283(6)Å c=23.017(2)Å

α=90.00° β=90.00° γ=90.00°

(4-Chlorophenyl)(4-hydroxypiperidin-1-yl)methanone--(4-chlorophenyl)(piperidin-1-yl)methanone (0.75/0.25)

0.75(C₁₂H₁₄Cl₁N₁O₂)_,0.25(C₁₂H₁₄Cl₁N₁O₁)

Revathi, B. K.Reuben Jonathan, D.Kalai Sevi, K.Dhanalakshmi, K.Usha, G.

Acta Crystallographica Section E (2015) 71, 11 o896-o897

a=24.312(4)Å b=6.1628(10)Å c=7.9654(11)Å

α=90° β=90° γ=90°

(E)-1-(1-Hydroxynaphthalen-2-yl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one

C₂₂H₂₀O₅

Srividya, J.Reuben Jonathan, D.Revathi, B. K.Anbalagan, G.

Acta Crystallographica Section E (2015) 71, 8 o610-o611

a=8.4523(8)Å b=14.0414(12)Å c=15.1672(11)Å

α=90.00° β=94.623(3)° γ=90.00°

2,2,4-Trimethyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepine hemihydrate

C₁₂H₁₈N_2,0.5(H₂O)

Ezhilarasi, K. S.Akila, A.Ponnuswamy, S.Revathi, B. K.Usha, G.

Acta Crystallographica Section E (2015) 71, 8 o570-o571

a=9.0548(10)Å b=23.246(2)Å c=11.5613(14)Å

α=90° β=100.483(3)° γ=90°

(2E)-3-(3-Ethoxy-4-hydroxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one

C₁₇H₁₆O₄

Vasanthi, R.Reuben Jonathan, D.Elizhlarasi, K. S.Revathi, B. K.Usha, G.

Acta Crystallographica Section E (2014) 70, 11 o1202-o1203

a=16.3670(4)Å b=10.5512(3)Å c=16.6153(4)Å

α=90.00° β=90.00° γ=90.00°

Bis(prop-2-yn-1-yl) 5-nitroisophthalate

C₁₄H₉NO₆

Ezhilarasi, K. S.Selvarani, Sivasamy Rajakumar, Perumal Revathi, B. K.Usha, G.

Acta Crystallographica Section E (2015) 71, 6 o435

a=6.679(5)Å b=11.679(5)Å c=16.503(5)Å

α=90.000(5)° β=90.000(5)° γ=90.000(5)°

2-Chloro-1-(3,3-dimethyl-2,6-diphenylpiperidin-1-yl)ethanone

C₂₁H₂₄ClNO

Prathebha, K.Revathi, B. K.Usha, G.Ponnuswamy, S.Abdul Basheer, S.

Acta Crystallographica Section E (2013) 69, 9 o1424

a=7.5488(6)Å b=9.9706(7)Å c=12.9887(10)Å

α=106.783(4)° β=93.022(4)° γ=102.347(4)°

Methyl 4'-(4-fluorophenyl)-1'-methyl-3'-nitromethyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate

C₂₁H₂₀FN₃O₅

Revathi, B. K.Sathya, S.Usha, G.Murugan, G.Bakthadoss, M.

Acta Crystallographica Section E (2013) 69, 2 o278

a=8.0265(5)Å b=25.7011(15)Å c=9.7763(6)Å

α=90.00° β=90.00° γ=90.00°

Structures by: Revathi B. K.

Total: 20

<i>N</i>,<i>N</i>'-(Ethane-1,2-diyl)bis(2-chlorobenzamide)

(<i>E</i>)-1-(4-Aminophenyl)-3-[4-(benzyloxy)phenyl]prop-2-en-1-one

(<i>E</i>)-4-(4-Ethoxyphenyl)but-3-en-2-one

2,4-Dichloro-<i>N</i>-{[1-(2,4-dichlorobenzoyl)piperidin-4-yl]methyl}benzamide

(4-Chlorophenyl)(4-methylpiperidin-1-yl)methanone

4-Chloro-<i>N</i>-[2-(piperidin-1-yl)ethyl]benzamide monohydrate

2-Chloro-1-(3-ethyl-2,6-diphenylpiperidin-1-yl)ethanone

3-(4-Methoxyphenyl)-2,3-dihydro-1<i>H</i>-naphtho[2,1-<i>b</i>]pyran-1-one

4-Methyl-<i>N</i>-[2-(piperidin-1-yl)ethyl]benzamide monohydrate

(<i>E</i>)-3-(3,4-Dimethoxyphenyl)-1-(1-hydroxynaphthalen-2-yl)prop-2-en-1-one

(4-Hydroxypiperidin-1-yl)(4-methylphenyl)methanone

[4-(Chloromethyl)phenyl](4-hydroxypiperidin-1-yl)methanone

(4-Hydroxypiperidin-1-yl)[4-(trifluoromethyl)phenyl]methanone

(4-Chlorophenyl)(4-hydroxypiperidin-1-yl)methanone--(4-chlorophenyl)(piperidin-1-yl)methanone (0.75/0.25)

(<i>E</i>)-1-(1-Hydroxynaphthalen-2-yl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one

2,2,4-Trimethyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine hemihydrate

(2<i>E</i>)-3-(3-Ethoxy-4-hydroxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one

Bis(prop-2-yn-1-yl) 5-nitroisophthalate

2-Chloro-1-(3,3-dimethyl-2,6-diphenylpiperidin-1-yl)ethanone

Methyl 4'-(4-fluorophenyl)-1'-methyl-3'-nitromethyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate